On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES

On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES

Background Diabetes mellitus and high platelet reactivity (HPR) on clopidogrel are both associated with increased risk of ischemic events after percutaneous coronary intervention, but whether the HPR‐associated risk of adverse ischemic events differs by diabetes mellitus status is unknown. Methods a...

Full description

Bibliographic Details
Main Authors: Bahira Shahim, Björn Redfors, Thomas D. Stuckey, Mengdan Liu, Zhipeng Zhou, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Franz‐Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Bruce R. Brodie, Iva Srdanovic, Mahesh V. Madhavan, Ernest L. Mazzaferri, Roxana Mehran, Ori Ben‐Yehuda, Ajay J. Kirtane, Gregg W. Stone
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
diabetes mellitus
drug‐eluting stent
percutaneous coronary intervention
platelet reactivity
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.026482

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.026482

Similar Items